Search results
Results from the WOW.Com Content Network
This is a list of investigational autism and pervasive developmental disorder drugs, or drugs that are currently under development for clinical use in the treatment of autistic spectrum disorders and/or other pervasive developmental disorders but are not yet approved.
Glipizide, sold under the brand name Glucotrol among others, is an anti-diabetic medication of the sulfonylurea class used to treat type 2 diabetes. [ 1 ] [ 2 ] It is used together with a diabetic diet and exercise.
The Center for Autism and Related Disorders (CARD), [Fresno] - A specialized institution providing educational and therapeutic services to individuals with autism spectrum disorder. [ 2 ] Connecticut
Pages in category "Autism-related organizations based in the United States" The following 46 pages are in this category, out of 46 total. This list may not reflect recent changes .
Cumberland County Christian School is already at capacity for the 2023-24 school year with 125 students, but Respus is opening a new school to specifically serve children with mild to moderate autism.
Glucagon-like peptide-1 (GLP-1) receptor agonists, also known as GLP-1 analogs, GLP-1DAs, or incretin mimetics, [1] are a class of anorectic drugs that reduce blood sugar and energy intake by activating the GLP-1 receptor.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
The Center for Autism and Related Disorders, Inc. (CARD) is an organization that provides a range of services based on applied behavior analysis (ABA) for children and adults on the autism spectrum. CARD was founded in 1990 by Doreen Granpeesheh. The Blackstone Group, a private equity firm, acquired CARD in 2018.